GSK UK has specified a complete line for packaging the three devices at a speed of 140 per minute.
The devices include a biopharmaceutical product used to treat patients who suffer from severe eosinophilic asthma and another biopharmaceutical injection for treatment of Lupus.
Marchesini's line comprises six machines and five robots, capable of handling two different sizes: single device laid flat or four devices positioned next to each other.
The line has been designed for rapid size change and line clearance operations and just successfully completed all OQ Qualification activities with PQ planned in July 20.
Upstream from the GSK line there is a tray emptying unit to feed the trays with the devices.
A Gigacombi followed by a Robocombi empty the devices from the trays and feed them onto the conveyor belt connected to the twin-head labeller RE 302 2T, which wraps a label around the device and applies additional labels on the front and back.
The RE 302, by Marchesini subsidiary Neri Division, offers access and visibility of the work area and quick size change-over operations with digital indicators.
Marchesini's line comprises six machines and five robots, capable of handling two different sizes
It can also can handle products made from different materials, from glass to plastic, but also various shapes and sizes, be they round, oval or any other unconventional shape.
A second Robocombi takes the labelled device and transfers it to the machine of the supplier, Waldner, which puts it into the moulds with the thermoformed cases.
Once sealed, the cases with the devices reach the MA 255 continuous-motion horizontal cartoner with Robocombi, which puts them into the carton together with the information leaflet.
The cartons are then weighed on an external weighing unit and transported towards the labeller BL A-420, which performs serialization, stamping and sealing operations.
The MCP840 TT monobloc casepacker-palletizer equipped with a Gigacombi completes the packaging process.
The MCP840 TT measures 160x120x120-500x350x350mm and meets all requirements related to drug serialization and traceability.
Both the labeller and the casepacker-palletizer are fitted with Sea Vision systems to satisfy international regulations for visual control and labelling for fully serialised product supply assurance.
Nigel Wood, Eng. Capital Dir. GSK BC said, "This has been a fantastic team effort between Marchesini Group, Waldner and GSK Teams delivered through the adversity of Covid challenges"